SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Amanat, Fatima, Thapa, Mahima, Lei, Tinting, Ahmed, Shaza M. Sayed, Adelsberg, Daniel C., Carreño, Juan Manuel, Strohmeier, Shirin, Schmitz, Aaron J. +39 more·2021·Cell

DOI 10.1016/j.cell.2021.06.005

Cited by (276)

Items 101–200 of 276

Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients With Different Severities
Xu Li, Manik Garg, Tingting Jia, Qijun Liao, Lifang Yuan, Li Mao, Zhengyu Wu, Weihua Wu, Yalan Bi, Nancy George et al. · 2022 · Frontiers in Immunology
Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals
Mariliis Jaago, Annika Rähni, Nadežda Pupina, Arno Pihlak, Helle Sadam, Jürgen Tuvikene, Annela Avarlaid, Anu Planken, Margus Planken, Liina Haring et al. · 2022 · Scientific Reports
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination
Juan Manuel Carreño, Ariel J. Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir I. Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta et al. · 2023 · Science Translational Medicine
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
Jeffrey Seow, Carl Graham, Sadie R. Hallett, Thomas Lechmere, Thomas J. A. Maguire, Isabella Huettner, Daniel Cox, Hataf Khan, Suzanne Pickering, Rebekah Roberts et al. · 2022 · Cell Reports
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans
Alice Cho, Frauke Muecksch, Zijun Wang, Tarek Ben Tanfous, Justin DaSilva, Raphael Raspe, Brianna A. Johnson, Eva Bednarski, Víctor Ramos, Dennis J. Schaefer-Babajew et al. · 2022 · The Journal of Experimental Medicine
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals
Stéphanie Longet, Alexander Hargreaves, Saoirse Healy, Rebecca L. Brown, Hailey R. Hornsby, Naomi Meardon, Tom Tipton, Eleanor J. Barnes, Susanna Jane Dunachie, Christopher James Arthur Duncan et al. · 2022 · Frontiers in Immunology
Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination
Iana H. Haralambieva, Jonathon M. Monroe, Inna G. Ovsyannikova, Diane E. Grill, Gregory A. Poland, Richard B. Kennedy · 2022 · The Journal of Infectious Diseases
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike
Timothy J.C. Tan, Abhishek Kumar Verma, Abby E. Odle, Ruipeng Lei, David Kyle Meyerholz, Kenneth A. Matreyek, Stanley M. Perlman, Lok-Yin Roy Wong, Nicholas C. Wu · 2024 · Proceedings of the National Academy of Sciences
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel
Kevin W. Ng, Nikhil Faulkner, Antoni G. Wrobel, Steve J. Gamblin, George Kassiotis · 2021 · Seminars in Immunology
A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features
Saman Fatihi, Surabhi Rathore, Ankit Kumar Pathak, Deepanshi Gahlot, Mitali Mukerji, Nidhi Jatana, Lipi Thukral · 2021 · Current Research in Structural Biology
Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus
Fatima Amanat, Shirin Strohmeier, Philip S. Meade, Nicholas Dambrauskas, Barbara Mühlemann, Derek J. Smith, Vladimir I. Vigdorovich, D. Noah Sather, Lynda Coughlan, Florian Krammer · 2021 · PLoS Biology
COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins
Evan A. Elko, Georgia A. Nelson, Heather Mead, Erin Kelley, Sophia T. Carvalho, Nathan Sarbo, Caroline E. Harms, Virginia Le Verche, Angelo A. Cardoso, Jennifer L. Ely et al. · 2022 · Cell Reports
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Sapna Sharma, Thomas Vercruysse, Lorena Sánchez-Felipe, Winnie Kerstens, Madina Rasulova, Lindsey Bervoets, Carolien De Keyzer, Rana Abdelnabi, Caroline Shi-Yan Foo, Viktor Lemmens et al. · 2022 · Nature Communications
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, Sibo Zhang, Hong Wang, Hongjing Liu, Ying Gu, Ningshao Xia, Shaowei Li · 2024 · Viruses
The unique evolutionary dynamics of the SARS-CoV-2 Delta variant
Adi Stern, Shay Fleishon, Talia Kustin, Edo Dotan, Michal Mandelboim, Oran Erster, Ella Mendelson, Orna Mor, Neta S. Zuckerman · 2021 · medRxiv
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
Juan Manuel Carreño, Hala Alshammary, Johnstone Tcheou, Gagandeep Singh, Ariel J. Raskin, Hisaaki Kawabata, Levy A. Sominsky, Jordan J. Clark, Daniel C. Adelsberg, Dominika A. Bielak et al. · 2021 · medRxiv
Enzyme-Linked Immunosorbent Assay: An Adaptable Methodology to Study SARS-CoV-2 Humoral and Cellular Immune Responses
Amanda Izeli Portilho, Gabrielle Gimenes Lima, Elizabeth De Gaspari · 2022 · Journal of Clinical Medicine
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination
Fatima Amanat, Jordan J. Clark, Juan Manuel Carreño, Shirin Strohmeier, Temima Yellin, Philip S. Meade, Disha Bhavsar, Hiromi Muramatsu, Weina Sun, Lynda Coughlan et al. · 2023 · Journal of Virology
Germinal centre-driven maturation of B cell response to SARS-CoV-2 vaccination
Wooseob Kim, Julian Q. Zhou, Alexandria J. Sturtz, Stephen C. Horvath, Aaron J. Schmitz, Tingting Lei, Elizaveta Kalaidina, Mahima Thapa, Wafaa B. Alsoussi, Alem Haile et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins
Zi-Jun Wang, Frauke Muecksch, Alice Cho, C. Gaebler, H. Hoffmann, Victor A. Ramos, Shuaizhou Zong, M. Cipolla, Bryant Johnson, Fabian Schmidt et al. · 2022 · bioRxiv
The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines
Kensaku Murano, Youjia Guo, Haruhiko Siomi · 2021 · Biochemical Society Transactions
Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2’s evasive maneuvering
Michael W. Grunst, Pradeep Devappa Uchil · 2022 · Cell Reports Medicine
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern
Ryan P. McNamara, Jenny S. Maron, Julie Boucau, Vicky Roy, Nicholas E. Webb, Harry L. Bertera, Amy K. Barczak, The Staff, Nicholas Franko, Jennifer K. Logue et al. · 2023 · mBio
Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, Vic Arendt, Thérèse Staub, Rejko Krüger, Guy Fagherazzi, Paul Wilmes, Judith M. Hübschen, Markus W. Ollert et al. · 2023 · International Journal of Molecular Sciences
SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study
Paola Kučan Brlić, Martina Pavletić, Mate Lerga, Fran Krstanović, Marina Pribanić Matešić, Karmela Miklić, Suzana Malić, Leonarda Mikša, Maja Pajcur, Dolores Peruč et al. · 2022 · Viruses
Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
Zhiyang Ling, Chunyan Yi, Xiaoyu Sun, Zhuo Yang, Bing Sun · 2022 · Science China Life Sciences
A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
Shugang Qin, Hai Huang, Wen Xiao, Kepan Chen, Xi He, Xiaoshan Tang, Zhiying Huang, Yupei Zhang, Xing Duan, Na Fan et al. · 2023 · Acta Pharmaceutica Sinica B
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
Leonie Mayer, Leonie Marie Weskamm, Anahita Fathi, Maya Kono, Jasmin Heidepriem, Verena Krähling, Sibylle C. Mellinghoff, My Linh Ly, Monika Friedrich, Svenja Hardtke et al. · 2024 · npj Vaccines
Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike
Xiaodi Yu, Jarek Juraszek, Lucy Rutten, Mark J. G. Bakkers, Sven Blokland, Jelle M. Melchers, Niels J. F. van den Broek, Annemiek Verwilligen, Pravien D. Abeywickrema, Johan Vingerhoets et al. · 2023 · PLoS Pathogens
The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera
Gagandeep Singh, Anass Abbad, Giulio Kleiner, Komal Srivastava, Charles Gleason, PARIS Study Group, Juan Manuel Carreño, Viviana R. Simon, Florian Krammer, Dalles Andre et al. · 2023 · mBio
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells
Kilian A. Wietschel, Kevin Fechtner, Elmer Antileo, Goran Abdurrahman, Chiara A. Drechsler, Michelle Kudzayi Makuvise, Ruben Rose, Mathias Voß, Andi Krumbholz, Stephan Michalik et al. · 2024 · Frontiers in Immunology
Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination
Ekaterina A. Astakhova, Maria G. Byazrova, Gaukhar M. Yusubalieva, Кулемзин Сергей Викторович, Natalia A. Kruglova, Alexei G. Prilipov, Vladimir P. Baklaushev, Andrey A. Gorchakov, Alexander V. Taranin, Alexander V. Filatov · 2022 · Cells
SARS-CoV-2 Genetic Diversity and Lineage Dynamics in Egypt during the First 18 Months of the Pandemic
W. Roshdy, Mohamed K. Khalifa, J. E. San, Houriiyah Tegally, E. Wilkinson, Shymaa Showky, Darren P. Martin, M. Moir, A. Naguib, Nancy Elguindy et al. · 2022 · Viruses
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, Amy W. Chung, Kevin John Selva · 2023 · Frontiers in Immunology
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms
Diego M. Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, on behalf of the Ambulatorio Medico San Luca Villanuova Group, Lucia Lopalco et al. · 2022 · Vaccines
Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
Juan Manuel Carreño, Damodara Rao Mendu, Viviana R. Simon, Masood A Shariff, Gagandeep Singh, Vidya P. Menon, Florian Krammer · 2021 · iScience
Germinal center–mediated broadening of B cell responses to SARS-CoV-2 booster immunization
Sameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, Wafaa B. Alsoussi, Tamarand L. Darling, Bernadeta Dadonaite, Alesandro Civljak, Stephen C. Horvath, Julian Q. Zhou, Wooseob Kim et al. · 2025 · Science Immunology
Advances in understanding the formation and fate of B-cell memory in response to immunization or infection
Liam C. Kealy, Kim L. Good‐Jacobson · 2021 · Oxford Open Immunology
SARS-CoV-2 mRNA vaccination induces an intranasal mucosal response characterized by neutralizing antibodies
Kevin T. Cao, Catalina Cobos-Uribe, Noelle Knight, Rithika Jonnalagadda, Carole Robinette, Ilona Jaspers, Meghan E. Rebuli · 2023 · Journal of Allergy and Clinical Immunology Global
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles
Paulina Kapłonek, Deniz Cizmeci, Stephanie Fischinger, Ai-ris Yonekura Collier, Todd J. Suscovich, Caitlyn Linde, Thomas A. Broge, Colin J. Mann, Fatima Amanat, Diana Dayal et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Integrating core subtractive proteomics and reverse vaccinology for multi-epitope vaccine design against Rickettsia prowazekii endemic typhus
Ariba Khan, Muhammad Hassan Khanzada, Kanwal Khan, Khurshid Jalal, Reaz Uddin · 2023 · Immunologic Research
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Andrew P. Hederman, Harini Natarajan, Leo Heyndríckx, Kevin K. Ariën, Joshua A. Wiener, Peter F. Wright, Evan M. Bloch, Aaron A.R. Tobian, Andrew D. Redd, Joel N. Blankson et al. · 2023 · Nature Communications
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
Daryl Geers, Roos S. G. Sablerolles, Debbie van Baarle, Neeltje A. Kootstra, Wim J. R. Rietdijk, Katharina S. Schmitz, Lennert Gommers, Susanne Bogers, Nella J. Nieuwkoop, Laura L.A. van Dijk et al. · 2022 · iScience
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 in mice
Pritesh Desai, Courtney E. Karl, Baoling Ying, Chieh-Yu Liang, Tamara García‐Salum, Ana Carolina Santana, Felipe ten-Caten, Joseph F. Urban, Sayda M. Elbashir, Darin K. Edwards et al. · 2024 · Science Translational Medicine
Exploring and Monitoring the Reasons for Hesitation with COVID-19 Vaccine Based on Social-Platform Text and Classification Algorithms
Jingfang Liu, Shuangjinhua Lu, Caiying Lu · 2021 · Healthcare
Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
Doris Urlaub, Natalie Wolfsdorff, Jan‐Erik Hoffmann, Stefanie Dorok, Markus Hoffmann, Moritz Anft, Naomi Pieris, Patrick S. Günther, Bernhard Schaaf, Uwe Cassens et al. · 2022 · European Journal of Immunology
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
Marianne Graninger, Jeremy Vann Camp, Stephan Walter Aberle, Marianna Theresia Traugott, Wolfgang Hoepler, Elisabeth Puchhammer‐Stöckl, Lukas Weseslindtner, Alexander Zoufaly, Judith Helene Aberle, Karin Stiasny · 2022 · Frontiers in Immunology
Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies
Christian Albert Devaux, Jacques Fantini · 2023 · Pathogens
Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology
Aaruni Khanolkar · 2021 · Cells
Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19
Latifa Zayou, Swayam Prakash, Hawa Vahed, Nisha Rajeswari Dhanushkodi, Afshana Quadiri, Ahmed Belmouden, Zohra Lemkhente, Aziz Alami Chentoufi, Daniel Gil, Jeffrey B. Ulmer et al. · 2025 · Frontiers in Immunology
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
Sara Stinca, Thomas W. Barnes, Vogel Peter, Wilfried Meyers, Johannes Schulte-Pelkum, Daniel Filchtinski, Laura Steller, Thomas Hauser, Sandro Manni, David Gardiner et al. · 2021 · PLoS ONE
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
Frédéric Baron, Lorenzo Canti, Kevin K. Ariën, Delphine Kemlin, Isabelle Desombere, Margaux Gerbaux, Pieter Pannus, Yves P. Beguin, Arnaud Marchant, Stéphanie Humblet‐Baron · 2022 · Frontiers in Immunology
Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response
Lynn Su, Wanzhi Huang, Frederick H. Neill, Mary Kolb Estes, Robert L. Atmar, Timothy Gerald Palzkill · 2023 · npj Vaccines
What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders
E. Maggi, B. Azzarone, G. Canonica, L. Moretta · 2021 · Allergy. European Journal of Allergy and Clinical Immunology
Microfluidic particle counter visualizing mucosal antibodies against SARS-CoV-2 in the upper respiratory tract for rapid evaluation of immune protection
Jiaheng Li, Lok Ting Chu, Hogi Hartanto, Guihuan Guo, Lu Liu, Jianpeng Wu, Minghui Wu, Chenyu Cui, Gaobo Wang, Wengang Liu et al. · 2024 · Lab on a Chip
Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination
Richard S. H. Lee, Samuel M. S. Cheng, Jin Zhao, Annie Y. S. Tsoi, Kaman K. M. Lau, CoCo H. C. Chan, John K. C. Li, David S.C. Hui, Malik J. S. Peiris, Hui‐Ling Yen · 2024 · Influenza and Other Respiratory Viruses
Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2
Carolyn A. Cohen, Nancy Leung, Prathanporn Kaewpreedee, Kelly W. K. Lee, Janice Zhirong Jia, Alan W. L. Cheung, Samuel M. S. Cheng, Masashi Mori, Dkm Ip, Leo L. M. Poon et al. · 2024 · Nature Communications
Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2
Siriruk Changrob, Atsuhiro Yasuhara, Suncheol Park, Sandhya Bangaru, Lei Li, Chloe A. Troxell, Peter Halfmann, Steven A. Erickson, Nicholas Catanzaro, Meng Yuan et al. · 2025 · The Journal of Experimental Medicine
Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization
Stefania Dispinseri, Ilaria Marzinotto, Cristina Brigatti, Maria Franca Pirillo, Monica Tolazzi, Elena Bazzigaluppi, Andrea Canitano, Martina Borghi, Alessandra Gallinaro, Roberta Caccia et al. · 2022 · Journal of Clinical Immunology
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights
Sophie R O’Reilly, Joanne Byrne, Eoin R. Feeney, Patrick W. G. Mallon, Virginie Gautier · 2024 · Vaccines
Design of the conserved epitope peptide of SARS-CoV-2 spike protein as the broad-spectrum COVID-19 vaccine
Ting-Yu Chang, Chia‐Jung Li, Tai‐Ling Chao, Sui‐Yuan Chang, Shih‐Chung Chang · 2024 · Applied Microbiology and Biotechnology
Characterization of neutralizing versus binding antibody and T cell responses to varicella-zoster virus in the elderly
Suthee Mangmee, Supasek Kardkarnklai, Suphanun Phuphanitcharoenkun, Sarocha Suthisawat, Oranit Likhit, Nattaya Kamchompoo, Rae Apaivongse Coad, Patimaporn Wongprompitak, Jarupa Soongsathitanon, Tararaj Dharakul et al. · 2025 · Scientific Reports
The immunological impact of revaccination in a hybrid-immune world
Mary T. Bausch-Jurken, Galit Alter · 2025 · Frontiers in Immunology
SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination
Shishan Teng, Yabin Hu, You Wang, Yinggen Tang, Qian Wu, Xingyu Zheng, Rui Lü, Dong Pan, Fen Liu, Tianyi Xie et al. · 2024 · Frontiers in Immunology
Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug et al. · 2022 · PLoS Pathogens
Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection
Chiara Piubelli, Alessandra Ruggiero, Lucia Calciano, Cristina Mazzi, Concetta Castilletti, Natalia Tiberti, Sara Caldrer, Matteo Verzè, Silvia Stefánia Longoni, Simone Accordini et al. · 2023 · EBioMedicine
SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations
Andrew P. Hederman, Harini Natarajan, Joshua A. Wiener, Peter F. Wright, Evan M. Bloch, Aaron A.R. Tobian, Andrew D. Redd, Joel N. Blankson, Amihai Rottenstreich, Gila Zarbiv et al. · 2022 · medRxiv
A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database
Hassan Hussein Musa, Taha Hussein Musa · 2022 · Human Vaccines & Immunotherapeutics
Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti–SARS-CoV-2 antibodies in the absence of CXCL13
Marne Azarias-da-Silva, Pierre Nioche, Calaiselvy Soudaramourty, Anne Bull-Maurer, Mounira Tiouajni, Dechuan Kong, Ouafa Zghidi‐Abouzid, Morgane Picard, Ana Mendes‐Frias, André Santa Cruz et al. · 2023 · Science Advances
Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
Xingsu Gao, Linlin Fan, Binyang Zheng, Haoze Li, Jiwei Wang, Li Zhang, Jingxin Li, Fengcai Zhu · 2022 · Human Vaccines & Immunotherapeutics
Neutralization Heterogeneity of Circulating SARS-CoV-2 Variants to Sera Elicited by a Vaccinee or Convalescent
Meng Zhang, Yixin Gong, Shunchang Jiao · 2022 · Future Virology
Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza
Zhu Nan Li, Feng Liu, Stacie N. Jefferson, Lauren Horner, Paul J. Carney, Michael D. L. Johnson, Jennifer P. King, Emily Toth Martin, Richard Kent Zimmerman, Karen J. Wernli et al. · 2022 · Clinical Infectious Diseases
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity
Haolin Liu, Pengcheng Wei, Qian Zhang, Katja Aviszus, Jared Linderberger, John Jeongseok Yang, Junfeng Liu, Zhongzhou Chen, Hassan Waheed, Lyndon Reynoso et al. · 2022 · International Journal of Molecular Sciences
Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
Entao Li, Qiuxue Han, Jinhao Bi, Shimeng Wei, Shen Wang, Ying Zhang, Jun Liu, Na Feng, Tiecheng Wang, Jun Wu et al. · 2023 · Frontiers in Immunology
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics
Matteo Broketa, A. Sokal, M. Mor, Pablo Canales-Herrerias, A. Perima, A. Meola, Ignacio Fernández, B. Iannascoli, Guilhem Chenon, Alexis Vandenberghe et al. · 2023 · JCI Insight
The Emergence of SARS-CoV-2 Variants With a Lower Antibody Response: A Genomic and Clinical Perspective
Suvro Biswas, Shafi Mahmud, Mohasana Akter Mita, Shamima Afrose, Md. Robiul Hasan, Gobindo Kumar Paul, Mst. Sharmin Sultana Shimu, Md. Salah Uddin, Shahriar Zaman, Moon Nyeo Park et al. · 2022 · Frontiers in Medicine
Serum concentration of antigen-specific IgG can substantially bias interpretation of antibody-dependent phagocytosis assay readout
Russell St. Germain, Emily L. Bossard, Lawrence Corey, Anton M. Sholukh · 2023 · iScience
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques
Hélène Letscher, Delphine Guilligay, Grégory Effantin, Axelle Amen, Guidenn Sulbarán, Judith A. Burger, Laëtitia Bossevot, Laura Junges, Marco Léonec, Julie Morin et al. · 2025 · npj Vaccines
Functional and structural basis of Omicron BA.3.2.1 spike
Yan Wang, Yanping Hu, Zhenhang Chen, Jing Zou, Ke Zhang, Ping Ren, Pei‐Yong Shi, Bo Liang, Xuping Xie · 2026 · Cell Reports
Mutational escape prevention by combination of four neutralizing antibodies that target RBD conserved regions and stem helix
Haoneng Tang, Yong Ke, Yunji Liao, Yanlin Bian, Yunsheng Yuan, Ziqi Wang, Yang Li, Hang Ma, Tao Sun, Baohong Zhang et al. · 2022 · Virologica Sinica
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
Baoling Ying, Chieh-Yu Liang, Pritesh Desai, Suzanne M. Scheaffer, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael Diamond · 2024 · Journal of Virology
A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants
Niklas Vesper, Yaneth M. Ortiz, Frauke Bartels-Burgahn, Jianying Yang, Kathrin de la Rosa, Matthias Tenbusch, Sebastian R. Schulz, Stephanie Finzel, Hans‐Martin Jäck, Hermann Eibel et al. · 2021 · Frontiers in Immunology
Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learner
Xin Wang, Mingda Hu, Bo Liu, Huifang Xu, Yuan Jin, Boqian Wang, Yunxiang Zhao, Jun Wu, Junjie Yue, Hongguang Ren · 2023 · Frontiers in Cellular and Infection Microbiology
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
Samantha Mackin, Pritesh Desai, Bradley M. Whitener, Courtney E. Karl, Meizi Liu, Ralph Steven Baric, Darin K. Edwards, Taras M. Chicz, Ryan P. McNamara, Galit Alter et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
PF-D-Trimer, a protective SARS-CoV-2 subunit vaccine: immunogenicity and application
Zhihao Zhang, Jinhu Zhou, Peng Ni, Bing Hu, Normand Jolicoeur, Shuang Deng, Qian Xiao, Qian He, Gai Li, Yan Zhi Xia et al. · 2023 · npj Vaccines
Antibody‐dependent NK‐cell and neutralizing antibody responses against the Spike protein of Wuhan‐Hu‐1 and Omicron BA.1 SARS‐CoV‐2 variants in vaccinated experienced and vaccinated naïve individuals
Eliseo Albert, Daniel Fernández‐Soto, Estela Giménez, J. M. Casanovas, João Zulaica, Beatriz Álvarez‐Rodríguez, Luciana Rusu, Ron Geller, Hugh T. Reyburn, David Navarro · 2023 · Journal of Medical Virology
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects
Richard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn, Tobias Max Nowacki, Jörn Arne Meier, Jonel Trebicka, Phil‐Robin Tepasse · 2023 · Vaccines
Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort
Michael Schöfbänker, Rieke Neddermeyer, Theresa Günther, MM Mueller, Marie-Luise Romberg, Nica Classen, Marc Tim Hennies, Eike Roman Hrincius, Stephan Ludwig, Joachim Kühn et al. · 2023 · Vaccines
Characterization and Fluctuations of an Ivermectin Binding Site at the Lipid Raft Interface of the N-Terminal Domain (NTD) of the Spike Protein of SARS-CoV-2 Variants
Marine Lefebvre, Henri Chahinian, Bernard La Scola, Jacques Fantini · 2024 · Viruses
Coronavirus Entry Inhibitors
Qiaoshuai Lan, Shuai Xia, Lu Lu · 2022 · Advances in experimental medicine and biology
B Cell Receptor Repertoire Kinetics after SARS-CoV-2 Infection and Vaccination
Prasanti Kotagiri, Federica Mescia, William M. Rae, Laura Bergamaschi, Zewen Kelvin Tuong, Lorinda Turner, Kelvin Hunter, Federico Pehuen Pereyra Gerber, Myra D.T. Hosmillo, Christoph Hess et al. · 2021 · SSRN Electronic Journal
Structural basis for antibody resistance to SARS-CoV-2 omicron variant
Gabriele Cerutti, Yicheng Guo, Lihong Liu, Zhening Zhang, Liyuan Liu, Yang Luo, Yiming Huang, Harris H. Wang, David D. Ho, Zizhang Sheng et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, Yuhao Li, Guha Asthagiri Arunkumar, James Brett Case, Seth J. Zost, Cory M. Acreman, Déborah Carolina Carvalho dos Anjos, Jason S. McLellan et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Single-molecule imaging prefusion intermediate conformations of MERS-CoV spike trimers in membrane during entry
Shuvankar Dey, Purba Pahari, Mridul Shukla, Raiees Andrabi, Dibyendu Kumar Das · 2025 · Cell Reports
Depending on Epitope Profile of COVID-19 mRNA Vaccine Recipients: Are They More Efficient Against the Arising Viral Variants? An Opinion Article
Nawal Abd El‐Baky, Amro Abd Al Fattah Amara · 2022 · Frontiers in Medicine
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Leonie Marie Weskamm, Paulina Tarnow, Charlotte Harms, Mélanie Huchon, Matthijs P. Raadsen, Monika Friedrich, Laura Rübenacker, Cordula Grüttner, Mariana Gabriela García, Till Koch et al. · 2024 · iScience
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections
Grace Quirk, Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Branden Lau, Chieh-Yu Liang, Jefferey L. Burgess, Katherine Ellingson, Shawn C. Beitel, James K. Romine et al. · 2025 · Nature Immunology
Structural Analysis of the SARS ‐ CoV ‐2 Spike N‐Terminal Domain Across Wild‐Type and Recent Variants: A Comparative Study
Miriana Quaranta, Allegra Via, Stefano Pascarella · 2025 · Proteins Structure Function and Bioinformatics
A Peptide-Based Assay Discriminates Individual Antibody Response to the COVID-19 Pfizer/BioNTech mRNA Vaccine
Immacolata Polvere, Serena Voccola, Alfredina Parrella, Gaetano Cardinale, Lucrezia Zerillo, Romualdo Varricchio, Jessica Raffaella Madera, Romania Stilo, Pasquale Vito, Tiziana Zotti · 2021 · Vaccines
Protective antigenic epitopes revealed by immunosignatures after three doses of inactivated SARS-CoV-2 vaccine
Mian Peng, Xiaowen Dou, Xiuming Zhang, Mingchen Yan, Dan Xiong, Ruiwei Jiang, Tong Ou, Aifa Tang, Xiqiu Yu, Feiqi Zhu et al. · 2022 · Frontiers in Immunology